Then to evaluate whether serum insulin or FBS can affect NAFLD severity, HOMA was replace by these two variables in a new multivariable linear regression model, however, none of these represented an independent significant effect. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.